TY - JOUR
T1 - Utility of the Modified Frailty Index to Predict Cardiac Resynchronization Therapy Outcomes and Response
AU - Milner, Aidan
AU - Braunstein, Eric D.
AU - Umadat, Goyal
AU - Ahsan, Hamza
AU - Lin, Juan
AU - Palma, Eugen C.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - The aim of the present study was to investigate the utility of the modified frailty index (mFI) to predict outcomes in patients who underwent cardiac resynchronization therapy (CRT) device implantation. A retrospective cohort study of patients undergoing CRT implantation or upgrade over a 5-year period was performed. The relation between the preprocedural 11-component mFI and clinical outcomes including 1-year mortality, periprocedural and 30-day adverse events, 30-day readmission, length of hospitalization after procedure, and response to CRT defined by changes in left ventricular ejection fraction and end-diastolic volume were studied. Of 283 patients studied, 134 (47.3%) were classified as frail (mFI ≥3). Frailty was associated with an increased risk of 1-year mortality (hazard ratio 5.87, p = 0.033 in multivariate analysis), and increased frequency of adverse events (p = 0.013), 30-day readmission (p = 0.0077), and postprocedural length of stay ≥3 days (p = 0.0005). Frail patients had significantly less echocardiographic response to CRT compared with nonfrail patients with change in left ventricular ejection fraction 6% versus 12% (p = 0.004) and change in left ventricular end-diastolic volume −19.9 versus −43.3 ml (p = 0.006). In conclusion, frailty as assessed by the mFI is associated with an increase in 1-year mortality, adverse events, 30-day readmission, length of stay, and poorer response to CRT after implantation.
AB - The aim of the present study was to investigate the utility of the modified frailty index (mFI) to predict outcomes in patients who underwent cardiac resynchronization therapy (CRT) device implantation. A retrospective cohort study of patients undergoing CRT implantation or upgrade over a 5-year period was performed. The relation between the preprocedural 11-component mFI and clinical outcomes including 1-year mortality, periprocedural and 30-day adverse events, 30-day readmission, length of hospitalization after procedure, and response to CRT defined by changes in left ventricular ejection fraction and end-diastolic volume were studied. Of 283 patients studied, 134 (47.3%) were classified as frail (mFI ≥3). Frailty was associated with an increased risk of 1-year mortality (hazard ratio 5.87, p = 0.033 in multivariate analysis), and increased frequency of adverse events (p = 0.013), 30-day readmission (p = 0.0077), and postprocedural length of stay ≥3 days (p = 0.0005). Frail patients had significantly less echocardiographic response to CRT compared with nonfrail patients with change in left ventricular ejection fraction 6% versus 12% (p = 0.004) and change in left ventricular end-diastolic volume −19.9 versus −43.3 ml (p = 0.006). In conclusion, frailty as assessed by the mFI is associated with an increase in 1-year mortality, adverse events, 30-day readmission, length of stay, and poorer response to CRT after implantation.
UR - http://www.scopus.com/inward/record.url?scp=85078264074&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078264074&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2019.12.049
DO - 10.1016/j.amjcard.2019.12.049
M3 - Article
C2 - 31992439
AN - SCOPUS:85078264074
SN - 0002-9149
VL - 125
SP - 1077
EP - 1082
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 7
ER -